Pnb Vesper Life Science Private Limited

Develops and markets allopathy molecules with government assistance for research projects.

2011 | Ernakulam, Kerala (India) | Active
Last Updated: November 17, 2024

Pnb Vesper Life Science Profile

Key Indicators

  • Authorised Capital ₹ 5.25 Cr
  • Paid Up Capital ₹ 5.12 Cr
  • Company Age 13 Year, 9 Months
  • Last Filing with ROC 31 Mar 2023
  • Revenue Growth 466.33%
  • Profit Growth 17.22%
  • Ebitda -213.65%
  • Net Worth 38.10%
  • Total Assets 1.87%

About Pnb Vesper Life Science

Pnb Vesper Life Science Private Limited (PVLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 May 2011 and has a history of 13 years and nine months. Its registered office is in Ernakulam, Kerala, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.25 Cr and a paid-up capital of Rs 5.12 Cr, as per Ministry of Corporate Affairs (MCA) records.

Padinjarethalakkal Balaram, Kalathil Pillai, and Navaneeth Vishnu serve as directors at the Company.

Company Details

  • Location

    Ernakulam, Kerala, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    pnbvesper.com

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U73100KL2011PTC028397

  • Company No.

    028397

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    13 May 2011

  • Date of AGM

    30 Sep 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Ernakulam

Industry

Pharma

Who are the key members and board of directors at Pnb Vesper Life Science?

Executive Team (1)

NameDesignationAppointment DateStatus
Padinjarethalakkal Balaram Country flag representing In Managing Director13-May-2011Current

Financial Performance of Pnb Vesper Life Science.

Pnb Vesper Life Science Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 466.33% increase. The company also saw a substantial improvement in profitability, with a 17.22% increase in profit. The company's net worth Soared by an impressive increase of 38.1%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
466.33%
Revenue from Operations
Total Assets
1.87%
Profit or Loss
17.22%
Net Worth
38.10%
EBITDA
-213.65%

What is the Ownership and Shareholding Structure of Pnb Vesper Life Science?

In 2022, Pnb Vesper Life Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Pnb Vesper Life Science?

Unlock and access historical data on people associated with Pnb Vesper Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Pnb Vesper Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pnb Vesper Life Science's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Pnb Vesper Life Science

Recent activity within the organization

  • Annual General Meeting

    Pnb Vesper Life Science Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

    30 Sep 2023

  • Balance Sheet

    Pnb Vesper Life Science Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Ernakulam.

    31 Mar 2023

  • Director Appointment

    Navaneeth Vishnu was appointed as a Director was appointed as a Director on 24 Sep 2019 & has been associated with this company since 5 years 5 months .

    24 Sep 2019

  • Director Appointment

    Kalathil Sadasivan Pillai was appointed as a Director was appointed as a Director on 30 Jan 2013 & has been associated with this company since 12 years 26 days .

    30 Jan 2013

  • Director Appointment

    Padinjarethalakkal Nanu Ezhuthassan Balaram was appointed as a Managing Director was appointed as a Managing Director on 13 May 2011 & has been associated with this company since 13 years 9 months .

    13 May 2011

  • Company Incorporation

    Pnb Vesper Life Science Private Limited was registered on 13 May 2011 with Roc Ernakulam & aged 13 years 9 months as per MCA records.

    13 May 2011

Recent News, Updates & Announcement

Frequently asked questions

  • What is the Incorporation or founding date of Pnb Vesper Life Science Private Limited?

    Pnb Vesper Life Science Private Limited was incorporated on 13 May 2011.

  • What is authorized share capital and paid-up capital of Pnb Vesper Life Science Private Limited?

    The authorized share capital of Pnb Vesper Life Science Private Limited is ₹ 5.25 Cr and paid-up capital is ₹ 5.12 Cr.

  • Who are the current board members & directors of Pnb Vesper Life Science Private Limited?

    Currently 3 directors are associated with Pnb Vesper Life Science Private Limited.

    • Padinjarethalakkal Nanu Ezhuthassan Balaram
    • Kalathil Sadasivan Pillai
    • Navaneeth Vishnu
  • What is the registered address of Pnb Vesper Life Science Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Pnb Vesper Life Science Private Limited is Door No.40/1045G 5Th Floor, Amrutha Towers M G Road India, Cochin, Kerala, 682011.

  • What is the corporate identification number (CIN) and company number of Pnb Vesper Life Science Private Limited?

    The corporate identification number (CIN) of Pnb Vesper Life Science Private Limited is U73100KL2011PTC028397 and the company number is 028397 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Pnb Vesper Life Science Private Limited?

    The Official website of Pnb Vesper Life Science Private Limited is https://www.pnbvesper.com

  • What has been the recent revenue trend for Pnb Vesper Life Science Private Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Pnb Vesper Life Science Private Limited has risen by 466.33%.

  • What change has been observed in the net worth of Pnb Vesper Life Science Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Pnb Vesper Life Science Private Limited has experienced an upsurge of 38.10%.

  • When was the last Balance Sheet of Pnb Vesper Life Science Private Limited filed with the ROC?

    The most recent Balance Sheet for Pnb Vesper Life Science Private Limited was filed with the ROC on 31 Mar 2023.

People also Viewed

Similar Companies Based on Pharma Contract R&D